Medicine and Dentistry
Diagnosis
100%
Severe Acute Respiratory Syndrome Coronavirus 2
94%
Infection
54%
Patient
50%
Syndrome
47%
COVID-19
41%
Hospital
36%
Immunoassay
31%
Analysis
31%
Reagent
23%
Immune Checkpoint Inhibitor
23%
Lateral Flow Assay
23%
Post-COVID-19
23%
Melanoma
23%
Therapeutic Procedure
21%
RNA
18%
Laboratory
18%
Enzyme Linked Immunosorbent Assay
15%
Disease
15%
Plaque Assay
9%
Virus RNA
9%
Nasopharyngeal Swab
9%
Nucleic Acid Analysis
9%
Virus DNA
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Assay
7%
Patient Referral
7%
Receptor Binding
7%
Virus Nucleocapsid
7%
Symptom
7%
Tumor Regression
5%
Prognosis
5%
Incidence
5%
Clinical Management
5%
Clinical Study
5%
Virus Genome
5%
Monotherapy
5%
Screening
5%
Malignant Neoplasm
5%
Therapeutics
5%
Combination Therapy
5%
Face
5%
Coronavirinae
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
70%
Heat
47%
COVID-19
26%
Neutralizing Antibody
23%
RNA Extraction
18%
Programmed Death-Ligand 1
11%
Immunoglobulin A
11%
Immunoglobulin M
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Viral Load
9%
Real-Time Polymerase Chain Reaction
8%
ID50
6%
Immune Escape
5%
Human Immunodeficiency Virus 1
5%
Immune Checkpoint Blockade
5%
Blocking Antibody
5%